Dr. Glaucomflecken Explains: Vasopressors or Fluids in Early Septic Shock (ARISE FLUIDS) @NEJMgroup
Dr. Glaucomflecken Explains: Vasopressors or Fluids in Early Septic Shock (ARISE FLUIDS) @NEJMgroup
Uploaded August 2026 | Updated September 2026, 2 weeks ago
This video in our partnership with @DGlaucomflecken summarizes the ARISE FLUIDS trial that examined whether hemodynamic resuscitation with early vasopressors versus more liberal fluids could affect outcomes in patients with septic shock. Access the full results for free: https://nej.md/DrG47
Dr. Glaucomflecken Explains: Vasopressors or Fluids in Early Septic Shock (ARISE FLUIDS)Advancing Health Equity in a Time of Retrenchment: On Equity, Value, and the Work AheadNEJM Interview: Loren Adler on regulatory strategies for addressing factors that make consolidati...Bepirovirsen for Chronic Hepatitis B (B-Well 1 and B-Well 2)NEJM Interview: Arnold Monto on the value and feasibility of various methods for evaluating the p...Image Challenge — May 28, 2026Original Article: Left Atrial Appendage Closure in Afib (CLOSURE-AF)Image Challenge — August 27, 2026Setmelanotide for the Treatment of Acquired Hypothalamic Obesity (TRANSCEND)NEJM This Week — May 7, 2026Meet the EquationDr. Glaucomflecken Explains: Triple-Antihypertensive Pill after Intracerebral Hemorrhage (TRIDENT)
NEJM Group |

Dr. Glaucomflecken Explains: Vasopressors or Fluids in Early Septic Shock (ARISE FLUIDS)

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER